Evaluating the Implementation and Impact of Standard-of-care Delivered Oncology Financial Navigation
NCT07281287
Summary
The purpose of this study is to understand the implementation and impact of a pragmatically-delivered oncology financial navigation program. The main questions it aims to answer are: 1. How did oncology financial navigation implementation strategies affect implementation outcomes? 2. What is the impact of financial navigation on patient financial hardship, quality of life, and psychological distress? 3. How were implementation strategies utilized to overcome barriers to oncology financial navigation? Researchers will examine secondary, standard-of-care collected, patient-reported data, electronic medical record data, and qualitative interview data to answer these questions.
Eligibility
Aim 1: Inclusion criteria: As oncology financial navigation will be implemented as standard of care, implementation outcomes will be evaluated for: 1. All patients with cancer seen at the University of Alabama at Birmingham (UAB) Medical Oncology clinic 2. UAB oncology financial navigators Exclusion criteria: None. Aim 2: Inclusion criteria: This will be a secondary data analysis of patient-reported data routinely collected since 2020, which will include: 1. Patients with cancer seen at the UAB Medical Oncology clinic 2. Patients with non-missing patient-reported outcome data Exclusion criteria: None. Aim 3: Inclusion criteria: 1. Patients who have received oncology financial navigation 2. Providers (oncology financial navigators, social workers, nurse managers, oncologists) involved with the oncology financial navigation program 3. Health system team members (billing specialists, cancer service line leadership) involved with the oncology financial navigation program Exclusion criteria: None.
Conditions4
Locations1 site
Browse More Trials
Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.
This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.
NCT07281287